Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists
Benefits of the maintenance approach include sustained appetite regulation, continued metabolic support, fewer side effects at lower doses, and easier dose escalation if weight begins to creep
By mimicking the natural effects of GLP-1, these medications offer a new avenue for those struggling with obesity or overweight, providing not only improved appetite control and satiety but also better blood sugar regulation
Hair loss has been observed in some patients, likely related to the rapid weight loss itself rather than the medication directly
Amygdala In the amygdala we observed elevated inflammation in response to a WD in females only and GE2 treatment reduced inflammation in males regardless of diet, but increased it in SD-fed females only ( Fig
[DOI] [PMC free article] [PubMed] [Google Scholar] 76.Levy D., Burstein R., Kainz V., Jakubowski M., Strassman A